Solventum Corporation (SOLV) vs Zimmer Biomet Holdings, Inc. (ZBH)
A side-by-side comparison of Solventum Corporation and Zimmer Biomet Holdings, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 13, 2026. Differences are shown without an overall score or investment verdict.
SOLV
Solventum Corporation
$89.13HealthcareDelayed quote: Sep 18, 2026, 12:45 PM EDT
ZBH
Zimmer Biomet Holdings, Inc.
$95.21HealthcareDelayed quote: Sep 18, 2026, 12:45 PM EDT
Total return — SOLV vs ZBH
growth of $100 · dividends reinvested · last 2ySOLV +12.5% (+6.1%/yr)ZBH -23.4% (-12.5%/yr)SOLV compounded faster over this window
SOLV ZBH
SOLV vs ZBH: by the numbers
- •ZBH is the larger company ($18.42B vs $15.44B market cap).
- •SOLV trades at the lower trailing earnings multiple (10.88 vs 23.17 P/E), one valuation lens rather than an overall verdict.
- •SOLV converts more revenue to profit (17.26% vs 9.48% net margin).
- •ZBH grew revenue faster over the past five years (2.89% vs 2.72% CAGR).
- •ZBH pays a dividend (1.01% yield), while SOLV has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | SOLV | ZBH |
|---|---|---|
| P/E ratio | 10.88 | 23.17 |
| Forward P/E | 12.45 | 11.16 |
| P/S ratio | 1.86 | 2.16 |
| P/B ratio | 3.22 | 1.46 |
| EV / EBITDA | 7.14 | 10.90 |
| FCF yield | N/A | 6.91% |
Profitability
| Metric | SOLV | ZBH |
|---|---|---|
| Gross margin | 54.69% | 61.62% |
| Operating margin | 24.99% | 15.73% |
| Net margin | 17.26% | 9.48% |
| ROE | 29.88% | 6.39% |
| ROIC | 15.85% | 5.51% |
Dividends
| Metric | SOLV | ZBH |
|---|---|---|
| Dividend yield | N/A | 1.01% |
| Payout ratio | N/A | 23.36% |
Growth (annualized)
| Metric | SOLV | ZBH |
|---|---|---|
| Revenue CAGR (5Y) | 2.72% | 2.89% |
| EPS CAGR (5Y) | 6.26% | N/A |
| FCF CAGR (5Y) | N/A | 6.49% |
| Total return CAGR (5Y) | N/A | -6.74% |
Frequently asked
- Which has the lower trailing P/E, SOLV or ZBH?
- SOLV has the lower trailing P/E: SOLV trades at 10.88 and ZBH at 23.17. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, SOLV or ZBH?
- Over the past five years, ZBH grew revenue faster — SOLV at a 2.72% CAGR versus ZBH at 2.89%.
- Does SOLV or ZBH pay a bigger dividend?
- ZBH pays a dividend (1.01% yield), while SOLV has no payments in the available dividend history.
- Is SOLV or ZBH more profitable?
- SOLV runs the higher net margin — SOLV at 17.26% versus ZBH at 9.48%.
Go deeper
Dig into the metrics
Solventum P/E ratioZimmer Biomet P/E ratioZimmer Biomet dividend yieldSolventum ROEZimmer Biomet ROESolventum operating marginZimmer Biomet operating marginSolventum revenue growthZimmer Biomet revenue growthSolventum free cash flowZimmer Biomet free cash flow
Solventum & Zimmer Biomet appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 13, 2026.